Lv4
748 积分 2025-01-03 加入
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
4天前
已完结
Sarcoidal reactions in regional lymph nodes of patients with early stage non–small cell lung cancer predict improved disease-free survival: a pilot case-control study
1个月前
已完结
Significance of coexistent granulomatous inflammation and lung cancer
1个月前
已完结
Surgical Results of Lung Cancer with Sarcoid Reaction in Regional Lymph Nodes
1个月前
已完结
Presence of concurrent sarcoid-like granulomas indicate better survival in cancer patients
1个月前
已完结
Sarcoid-like reaction mimicking disease progression in an ALK-positive lung cancer patient receiving lorlatinib
2个月前
已完结
Multi-Organ metabolic profiling with [18F]F-FDG PET/CT predicts pathological response to neoadjuvant immunochemotherapy in resectable NSCLC
2个月前
已完结
Prognostic value of circulating tumor DNA in operable non-small cell lung cancer: a systematic review and reconstructed individual patient-data based meta-analysis
3个月前
已完结
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non–Small Cell Lung Cancer
4个月前
已完结
P2.06.58 Predictive Value of Tumor Microenvironment Biomarkers in Neoadjuvant Immunotherapy Combined With Chemotherapy for Locally Advanced NSCLC
4个月前
已关闭
皖公网安备34019202002308
